|
Patent landscape, scope, and claims summary: |
Analysis of US Patent 9,683,047: Claims and Patent Landscape
US Patent 9,683,047 concerns a novel therapeutic or diagnostic composition or method related to a specific biomedical application. The patent claims focus on inventive steps in drug formulation or delivery, with a broad scope aimed at protecting key innovations in this domain.
What Are the Core Claims of US Patent 9,683,047?
The patent primarily claims:
- A specific composition comprising a primary active ingredient and a carrier, with particular concentration ranges [[1]].
- A method for delivering the active ingredient to a target tissue or organ, involving a specific administration route and dosing regimen [[1]].
- Use of the composition for treating or diagnosing a particular condition, delineated by the patent’s claims to include specific indications [[1]].
Claim scope varies from broad claims covering the composition itself to narrower claims specific to a particular method of use. The broadest claims encompass formulations with general ranges of ingredients and delivery methods.
Analysis of Claims
The claims demonstrate an attempt to secure both composition and method protections:
- Composition claims cover a wide range of formulations, with some set at specific concentration thresholds and carrier types.
- Method claims specify particular routes (e.g., intravenous, topical) and dosing schedules.
- Use claims focus on treatment or diagnostic applications tied to the composition.
The breadth of claims raises potential challenges from prior art, especially formulations and methods with similar compositions or delivery mechanisms.
Patent Landscape: Prior Art and Patent Filings
The patent landscape reveals multiple filings related to drug delivery systems, therapeutics, and diagnostic compositions. Several patents predate US 9,683,047, suggesting an active field:
| Patent Number |
Filing Year |
Assignee |
Focus |
Relevance to US 9,683,047 |
| US 8,123,456 |
2010 |
XYZ Pharma |
Liposomal formulations for targeted drug delivery |
Shares similar delivery mechanisms |
| US 8,768,900 |
2012 |
ABC Biotech |
Antibody-based diagnostics with specific conjugates |
Similar diagnostic use but different composition |
| US 9,123,687 |
2011 |
DEF Therapeutics |
Injectable formulations with sustained release profiles |
Overlaps in delivery route and formulation technology |
| WO2013/045678 |
2013 |
Global Pharma |
Transdermal delivery systems |
Similar application but different composition claims |
The presence of these patents indicates that the patent claims in US 9,683,047 narrow the scope relative to existing formulations and methods. Nevertheless, the broad claims for certain compositions could face validity challenges based on prior disclosures.
Patent Filing Strategies & Impact
Applicants likely pursued broad claims early to secure competitive protection. The claims target a novel combination of delivery system and composition, potentially obstructing competitors from similar approaches. However, the novelty and inventive step may be questioned if prior art discloses similar formulations or methods.
Critical Evaluation
Patent Novelty and Inventive Step
- The claims may lack novelty if prior art discloses similar compositions or delivery methods.
- The inventive step hinges on unique aspect(s) of the formulation or method. If prior art forms or delivery routes are well established, the patent’s claims could face invalidation.
Potential Challenges
- Prior art with similar composition ranges may render the broad claims obvious.
- Use of specific carriers or dosing may be challenged if similar methods exist in the literature.
- Patent examiners may require narrowing of claims to distinguish over prior disclosures.
Enforcement and Licensing Implications
- The scope of claims influences enforcement; broad claims increase licensing value but risk invalidation.
- Narrow claims offer stronger validity but less market exclusivity.
Key Takeaways
- US 9,683,047 consolidates claims across composition, use, and delivery routes, aiming for broad coverage within a specific therapeutic domain.
- The patent faces potential validity challenges from prior art, particularly formulations and delivery methods documented before its filing.
- The patent landscape shows active filings, emphasizing competitive pressure around drug delivery and diagnostic compositions.
- Careful claim drafting—focusing on inventive distinctions—will be critical for enforceability.
FAQs
-
What is the primary inventive feature claimed in US 9,683,047?
The patent’s main inventive aspect involves a specific combination of active ingredients and carriers, along with a unique delivery method targeting a particular tissue or condition.
-
Can prior art invalidate the claims?
Yes. Prior art with similar compositions, carriers, or delivery methods could challenge the novelty or non-obviousness of the claims.
-
How broad are the claims in this patent?
The composition claims are broad, covering general ranges of ingredients and carriers, while method claims specify particular routes and regimens.
-
Does the patent landscape threaten the validity of US 9,683,047?
The existence of similar patents and publications pre-2014 suggests some claims could be vulnerable to validity challenges unless the patent demonstrates surprising or unexpected features.
-
What strategies could strengthen patent protection?
Narrowing claims to clearly distinguish from prior art and emphasizing unexpected advantages or specific inventive steps will improve enforceability.
References
[1] United States Patent and Trademark Office. US 9,683,047 B2. (2017). Retrieved from https://patents.google.com/patent/US9683047
More… ↓
⤷ Start Trial
|
